AI early warning system for prostate and bladder cancer in Beijing men
Part of Cancer, Kidney & urinary clinical trials.
This trial is testing an AI-based early warning system to find prostate and bladder cancer earlier. It is for men over 50 living in Beijing who are willing to take part in the screening and follow-up process.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man aged 50 or older
- You live in Beijing and plan to stay there
- You are willing to have screening tests, fill out questionnaires, and come back for follow-up visits
- You have not had any other cancer (except non-melanoma skin cancer) or a prior prostate cancer
- You do not currently have a prostate infection or an active infection in your urinary system
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether an artificial intelligence (AI) program can help doctors decide when a prostate biopsy is needed. It is for men who have had a prostate MRI that shows either a low-risk (PIRADS 1-2) or uncertain (PIRADS 3) spot, along with a higher-than-normal PSA level. You may qualify if you have certain risk factors like a high PSA density, suspicious digital rectal exam, or family history of prostate cancer.
This study compares how well a doctor’s MRI reading (the PI-RADS score) and a computer AI tool detect prostate cancer. It may help improve how men get targeted biopsies and avoid missing important cancers.
This study tests an artificial intelligence (AI) tool that may improve how doctors detect prostate cancer using imaging and biopsy information. It could help better identify cancer that is suspected based on PSA blood tests and rectal exam findings.
This trial tests if an artificial intelligence system can improve MRI scans used to detect prostate cancer. You may join if your doctor has recommended a prostate biopsy and you have an MRI scan that can be reviewed by both radiologists and AI.
This study uses artificial intelligence to look at your MRI scans, tissue samples, and medical records to learn more about prostate cancer and find better ways to treat it. You may join if you've had prostate removal surgery or have advanced prostate cancer.
This study tests if an AI tool can improve the safety review of radiation treatment plans for prostate cancer. Patients continue their normal treatment while the AI helps doctors check the plans.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.